Cargando…

Using the Tools we Have: Low-efficacy Vaccines and HIV

Detalles Bibliográficos
Autor principal:	Zurakowski, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703742/ https://www.ncbi.nlm.nih.gov/pubmed/26844264 http://dx.doi.org/10.1016/j.ebiom.2015.12.007

Ejemplares similares

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials
por: Mookerjee, Rajeshwar P, et al.
Publicado: (2008)

The Patients We Have to See
por: Irwin, Kelly E.
Publicado: (2017)

Efficacy and effectiveness trials have different goals, use different tools, and generate different messages
por: Porzsolt, Franz, et al.
Publicado: (2015)

Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
por: Miller, Elizabeth
Publicado: (2022)

Qualitative research on community experiences in large HIV research trials: what have we learned?
por: Camlin, Carol S, et al.
Publicado: (2018)

COVID 19: Have we nailed it?
por: Gogia, Atul
Publicado: (2021)

Commentary: The times have changed: Are we listening?
por: Grover, A K
Publicado: (2019)

We have to get it right: Ensuring success
por: Mokdad, Ali H., et al.
Publicado: (2020)

Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
por: Bertolaccini, Luca, et al.
Publicado: (2020)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

Decisions at the end of life: have we come of age?
por: Emanuel, Linda, et al.
Publicado: (2010)

Conquering myopia: Have we hit pay dirt?
por: Kesarwani, Siddharth S
Publicado: (2017)

Modeling Water Resources: Have We Got it Right?
por: Havens, Karl E.
Publicado: (2001)

Breaking dogma for future therapy using stem cell - Where we have reached?
por: Verma, Rama S.
Publicado: (2016)

Recent progress in sepsis epidemiology – have we learned enough?
por: Gerlach, Herwig, et al.
Publicado: (2003)

Sufficient blood, safe blood: can we have both?
por: Bönig, Halvard, et al.
Publicado: (2012)

Gene expression in human sepsis: what have we learned?
por: Russell, James A
Publicado: (2011)

Metasynthetic Madness: What Kind of Monster Have We Created?
por: Thorne, Sally
Publicado: (2016)

Commentary: Malignant Glaucoma - Have we finally found an answer?
por: Kaushik, Sushmita
Publicado: (2019)

Surrogate end points of quality of life assessment: have we really found what we are looking for?
por: Tassinari, Davide
Publicado: (2003)

It is not enough that we require data to be shared; we have to make sharing easy, feasible and accessible too!
por: Hajduk, Gabriela Karolina, et al.
Publicado: (2019)

Cannabis use in first episode psychosis: what we have tried and why it hasn’t worked
por: McDonell, Michael G., et al.
Publicado: (2019)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Swine flu-have we learnt any lesson from the past?
por: Yadav, Sankalp, et al.
Publicado: (2015)

BMI Guidelines for Bariatric Surgery in Diabetes: How Low Can We Go?
por: Ryan, Donna H.
Publicado: (2012)

Prevalence of primary headaches: it is not the behavior, but still we have to pay attention to it!
por: Pascual, Julio
Publicado: (2011)

Have we found the prevention for intensive care unit-acquired paresis?
por: Ali, Naeem A
Publicado: (2010)

Wnt signaling in breast cancer: have we come full circle?
por: Brown, Anthony MC
Publicado: (2001)

Continuous glucose sensors for glycaemic control in the ICU: have we arrived?
por: Mesotten, Dieter
Publicado: (2013)

Continuous Glucose Monitoring in Pregnancy: We Have the Technology but Not All the Answers
por: Murphy, Helen R.
Publicado: (2013)

Autism Spectrum Disorder and Cannabidiol: Have We Seen This Movie Before?
por: Salgado, Carlos A., et al.
Publicado: (2018)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Does the combination use of two pain assessment tools have a synergistic effect?
por: Suzuki, Takeshi
Publicado: (2017)

Hypothermia, immune suppression and SDD: can we have our cake and eat it?
por: Polderman, Kees H
Publicado: (2011)

Do we now have a relevant animal model for breast cancer?
por: Gusterson, Barry, et al.
Publicado: (1999)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rqkujb6j4nrfn1kji2alurlfiu